snus approvals highlight fda’s failures in tobacco policy by michael mcgrady
-
Posted: July 15, 2024
Read more »"Snus Approvals Highlight FDA’s Failures In Tobacco Policy" By Michael McGrady
For the benefit of risk reduced product development in the global market, the federal Food and Drug Administration (FDA) recently approved modified risk orders for eight smokeless tobacco products.
This is a first in the history of the regulatory framework established under the Tobacco Control Act of 2009. Swedish Match, a global leader in pasteurized snus, oral products, and craft tobacco, was able to successfully navigate the modified risk tobacco products regulatory pathway for their General product line.
Acting FDA commissioner Norman Sharpless announced the orders on Oct 22., heralding the product approval process for new tobacco products as a viable regulatory framework.
“Today’s action demonstrates the viability of the pathway for companies to market-specific tobacco products as less harmful to consumers, but only following a thorough scientific evaluation by the FDA,” Sharpless said.
“Using